Actelion sales and marketing update

Actelion launched 0.016% Valchlor mechlorethamine in the U.S. to treat stage IA and IB mycosis fungoides, a type of cutaneous T cell lymphoma (CTCL). The wholesale acquisition cost is $2,900 for a 60...